Novel Challenges for the Therapeutics of Depression: Pharmacological Modulation of Interaction between the Intracellular Signaling Pathways Mediated by Ca2+ and cAMP
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 001-006
- https://doi.org/10.29328/journal.jatr.1001001
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Novel model for “calcium paradox” in sympathetic transmission of smooth muscles: Role of cyclic AMP pathwayCell Calcium, 2013
- Effects of Repeated Treatment with Phosphodiesterase-4 Inhibitors on cAMP Signaling, Hippocampal Cell Proliferation, and Behavior in the Forced-Swim TestThe Journal of pharmacology and experimental therapeutics, 2011
- Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP SignalingJournal of Neuroscience, 2011
- Linking structure to function: Recent lessons from inositol 1,4,5-trisphosphate receptor mutagenesisCell Calcium, 2010
- Diabetes-Associated Cognitive Impairment Is Improved by a Calcium Channel Blocker, NifedipineHypertension, 2008
- A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”International Psychogeriatrics, 2005
- The Management of Coexisting Depression in Patients with DementiaClinical Neuropharmacology, 1997
- Adenylyl cyclases and the interaction between calcium and cAMP signallingNature, 1995
- Adenosine Receptors Activate Adenylate Cyclase and Enhance Secretion from Bovine Adrenal Chromaffin Cells in the Presence of ForskolinJournal of Neurochemistry, 1988
- Calcium-dependent exocytosis in bovine adrenal medullary cells with leaky plasma membranesNature, 1978